Mergers and Acquisitions

Mergers and Acquisitions Articles

Shareholders of gold miner Newmont have approved the company's $10 billion acquisition of Goldcorp. Barring any regulatory hitches, the deal is expected to close this quarter.
Whether investors will see this as a great buy or as a bad sale may depend on multiple factors that are not yet fully known.
A firm controlled by Eddie Lampert has offered to buy the outstanding shares of Sears Hometown and Outlet stores he doesn't already own. The offer was rejected by a committee of the board, but that's...
Goldman Sachs has reinstated its coverage of Disney with a Buy rating on the heels of the media giant's $65 billion cash acquisition of Fox assets.
CommScope had a very rough fourth quarter of 2018, but they say that rising tides lift all ships, and CommScope has managed to recover almost all of its losses.
AmeriGas Partners is being acquired by UGI in what should be viewed as a consolidation rather than as a hostile merger.
There seems to be more consolidation within the semiconductor industry as ON Semiconductor has announced that it will be acquiring Quantenna Communications.
This is one of those mergers that is not getting the warm fuzzy feeling that management teams love to see.
If its latest move works as well as the test markets would indicate, then McDonald's very well may become the king of artificial intelligence within the fast-food industry.
Talks of a merger of Viacom and CBS reportedly have resumed. Together, they might be able to compete against these much larger competitors.
The proposed $1.7 billion merger between oil producers Penn Virginia and Denbury Resources has been called off. Long-standing opposition for one Penn Virginia shareholder was likely the major reason...
Shares of Nokia took it on the chin after the Finnish (and French) mobile and communications equipment maker warned of compliance issues at its Alcatel-Lucent business in a filing with the SEC.
SPI Energy shares made a massive gain on Thursday after the company announced that it has completed its second-stage acquisition of 100% of the equity interest of Heliohrisi.
Gene therapy may become the next frontier for drug companies seeking to make billions of dollars improving or even curing certain diseases.
Pfizer is looking to collaborate with Vivet on the development of its proprietary treatment for Wilson disease.